Experimental drug shows promise for chronic lymphocytic leukemia

09/30/2011 | Galway Advertiser (Ireland)

A molecule called PHA-767491 eliminates chronic lymphocytic leukemia cells in blood samples and could target dividing leukemia cells in lymph nodes, according to an Irish study published in Molecular Cancer Therapeutics. Results of the preclinical study gives "some hope for the future, especially as related trials with patients are already under way," said Corrado Santocanale of the National University of Ireland, Galway.

View Full Article in:

Galway Advertiser (Ireland)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ